Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Thillaivanan, S.
- An Analysis of Siddha Management among COVID-19 Positive Patients of TPEC COVID Care Center, Vellore, Tamilnadu — Feedback Report
Abstract Views :345 |
PDF Views:235
Authors
Affiliations
1 Government Hospital, Pernambut, Vellore – 635810, Tamil Nadu, IN
2 District Siddha Medical Hospital, Vellore, Tamil Nadu, IN
3 Indian Medicine and Homeopathy Department, Chennai – 600106, Tamil Nadu, IN
4 District Collector’s Office, Vellore – 632009, Tamil Nadu, IN
1 Government Hospital, Pernambut, Vellore – 635810, Tamil Nadu, IN
2 District Siddha Medical Hospital, Vellore, Tamil Nadu, IN
3 Indian Medicine and Homeopathy Department, Chennai – 600106, Tamil Nadu, IN
4 District Collector’s Office, Vellore – 632009, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 21, No 4 (2021), Pagination: 351-355Abstract
Siddha's system of medicine is the effective one to reduce the symptoms of many viral illnesses. Siddha's system of medicine in asymptomatic, mild to moderate Covid-19 Positive patients, will make them recognize its effectiveness, reduce the symptoms, and move into the traditional approach towards the deadliest pandemic disease Covid-19. The objective of this study is to evaluate the acceptance and benefit of integrative Siddha management among the mild, moderate and asymptomatic COVID patients through a feedback questionnaire in TPEC COVID Care Center, Vellore, Tamil Nadu (TPECThanthai Periyar Engineering College). 74 asymptomatic, mild to moderate Covid-19 Positive patients were observed 7 days from 14.07.2020 to 30.07.2020 in TPEC COVID Care Center, Vellore, Tamil Nadu. During this period, Siddha medicines were administrated along with Western medicine. At the end of the period, validated feedback questionnaires were used to collect information from 74 participants for evaluating the acceptance and benefit of integrative Siddha management.In the 74 patients of TPEC COVID Care Center, Vellore, 100% were taken the given Siddha drug properly. 82.4% had the most common symptoms and 52.7% had less common symptoms. 16.2% of cases developed gastric acidity and 1.3% developed mild dyspnea as an ADR. 91.8% were recommended the Siddha system to others. 93.2% reported excellent disease progress. 90.7% of Siddha doctors quoted for 'Excellent' service on covid patients. This feedback report explores the three important significance. (a) Siddha medicine having significant effectiveness (b) Siddha medicines have safety in covid-19 patients (c) overall services of Siddha doctors are appreciatable by the patients and Siddha system is recommended to others. This analysis report helps to provide the possibility of the Siddha system for further or future clinical trials.Keywords
COVID Care Center, Integrative Medicine, SARS CoV-2, Novel Corona Virus, Siddha System of Medicine.References
- Gangarapu K,Sathiyarajeswaran P,Kanakavalli K, Kumar KM, Kumar DR,Shreedevi MS, et al. In silico computational screening of kabasurakudineer - official siddha formulation and JACOM - Novel Herbal Coded Formulation Against SARS-CoV-2 Spike protein [Internet].2020, Apr 13. Available from: https://ssrn.com/abstract=3574412. http://dx.doi.org/10.2139/ssrn.3574412.
- Cyranoski D. 'We need to be alert: scientists fear the second coronavirus wave as China's lockdowns ease. Nature. 2020 [Epub ahead of print]. https://doi. org/10.1038/d41586-020-00938-0
- Zuo MZ, Huang YG, Ma WH, et al. Expert recommendations for tracheal intubation in critically ill patients with novel coronavirus disease. Chin Med Sci J. 2020; 35:105–9. https://doi.org/10.24920/003724
- Camilla R, Mirjam S, Peter S, Gisela B, Guenter F, Claudia W, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New Engl J Med. 2020; 382(10):970–1. https://doi.org/10.1056/NEJMc2001468
- Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 2020 Jan 20–28. Euro Surveill. 2020;25. https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062
- Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 Aug; 584(7820):257–61.
- World Health Organization, Regional Office for South-East Asia traditional herbal remedies for primary health care. WHO Regional Office for South-East Asia. 2010. https://apps.who.int/iris/andle/10665/206024
- Rakulini R. Classification of 4448 Diseases in Siddha System of Medicine - A Review. Journal of Complementary and Alternative Medical Research. 2020; 9(2):46–54. https://doi.org/10.9734/jocamr/2020/v9i230140
- Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptomstesting/symptoms.html?CDC_A A_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fabout%2F symptoms.html.
- Azer SA. COVID-19: Pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020; 37. https://doi.rg/10.1016/j.nmni.2020.100738
- A Molecular Docking Investigation of SARS- CoV-2’s Main Protease against Phytocomponents of Siddha Formulation Vishasura Kudineer
Abstract Views :140 |
PDF Views:81
Authors
S. Karthik Nagarajan
1,
M. Bakkiya Devi
2,
S. Thillaivanan
3,
K. S. Maanickha Chelvi
1,
A. Kanagarajan
1
Affiliations
1 Siddha Regional Research Institute, Under CCRS, Ministry of Ayush, Government of India, Thiruvananthapuram - 695012, Kerala, IN
2 National Institute of Siddha, Ministry of Ayush, Government of India, Chennai - 600047, Tamil Nadu, IN
3 Department of Indian Medicine and Homeopathy, Government of Tamil Nadu, IN
1 Siddha Regional Research Institute, Under CCRS, Ministry of Ayush, Government of India, Thiruvananthapuram - 695012, Kerala, IN
2 National Institute of Siddha, Ministry of Ayush, Government of India, Chennai - 600047, Tamil Nadu, IN
3 Department of Indian Medicine and Homeopathy, Government of Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 23, No 2 (2023), Pagination: 565-571Abstract
Background: Covid-19 disease is a Wuhan, China originated acute viral respiratory illness. Even though the development of numerous vaccines, the threat of the Covid-19 virus endures nearly two years after the outbreak. The new mutant strain omicron has now spread to several countries. As a result, newer antiviral therapy is required to overcome this scenario. Objective: This study is aimed at phytocomponents in the Siddha formulation, Vishasura Kudineer (VSK), it is widely used to manage fever and respiratory ailments and may be effective in combating the ongoing pandemic of novel coronavirus disease. Methodology: The principal protease 3CLpro of this new Coronavirus (SARS-CoV-2) is a possible focus for therapeutic development since it plays a major part in disease transmission. Molecular docking investigation for all active Phytocomponents found in the Siddha formulation Vishasura Kudineer with possible targets was carried in the major Protease of SARS-CoV-2 (PDB ID:6LU7). AutoDockTools was used to design and optimize the ligand structures. Results: Molecular docking of the 9 bioactive phytocomponents as Santalic acids (-6.39), Nimbolide (-6.38), Rutin, Aristolochic acid (-6.95), Glabridin (-7.53), Indirubin (-7.23), Sabinene (-5.36), β-vetivenene (-6.79), and Zingiberene (-6.47) from in the Siddha sastric formulation, Vishasura Kudineer performed on the SARS-CoV-2 Main Protease protein’s active site (PDB ID: 6LU7). These phytochemicals had significant molecular interaction with the active residues, indicating their distinct inhibitory potencies. Conclusion: Whether this Siddha formulation could be used to effectively treat and manage COVID-19 and its variants, further research and clinical studies need to be done.Keywords
Ayush, COVID-19, Molecular Docking, Network Pharmacology, Siddha MedicineReferences
- Muhammad Adnan Shereen, et al. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020; 91-98.https://doi.org/10.1016/j.jare.2020.03.005
- Rothe C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; 382:970-1. https://doi.org/10.1056/NEJMc2001468
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30183-5
- Covid-19.who.int. 2020. WHO Coronavirus Disease (COVID-19) Dashboard. [Online] Available from: https://covid19.who.in.
- My Gov. in. 2020. #Indiafightscorona COVID-19. [Online] Available from: https://www.mygov.in/covid-19.
- Muthiah K, Ganesan K, Ponnaiah M, Parameswaran S. Concepts of body constitution in traditional Siddha texts: A literature review. Journal of Ayurveda and Integrative Medicine. 2019; 10(2):131-4. https://doi.org/10.1016/j.jaim.2019.04.002
- Nagappan AG, Krishnaveni M, Monika T, Thillaivanan S, Selvamoorthy G. A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Siddha Medicinal herb Vilvam (Aeglemarmelos). International Journal of Ayurvedic Medicine. 2021; 12(3):506-512. https://doi.org/10.47552/ijam.v12i3.2138
- Kiran G, et al. In Silico computational screening of Kabasura- Official Siddha formulation and JACOM against SARS-CoV-2 spike protein, J Ayurveda Integr Med. https://doi.org/10.1016/j.jaim.2020.05.009
- Sabarianandh JV, Bernaitis L, Manimekalai K. COVID-19 in Siddha medicine: A review. SBV Journal of Basic, Clinical and Applied Health Science. 2020; 3(2):83-86. https://doi.org/10.5005/jp-journals-10082-02256
- Trott O, Olson AJ. AutoDockVina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry. 2010; 31(2):455-461. https://doi.org/10.1002/jcc.21334
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Research. 2000; 28(1):235-242. https://doi.org/10.1093/nar/28.1.235
- Morris GM, Goodsell DS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry. 1998; 19(14):1639-1662. https://doi.org/10.1002/(SICI)1096-987X(19981115) 19:14<1639::AID-JCC10>3.0.CO;2-B
- Solis FJ, Wets RJB. Minimization by Random Search Techniques. 1981; 6(1):19-30. Available from: http://www.jstor.org/stable/3689263. https://doi.org/10.1287/moor.6.1.19
- Alzohairy MA. Therapeutics role of Azadirachta indica (Neem) and their active constituents in diseases prevention and treatment. Evidence-Based Complementary and Alternative Medicine. 2016; 7382506:11. https://doi.org/10.1155/2016/7382506
- Warjeet S Laitonjam, et al. Comparative study of the major components of the indigo dye obtained from Strobilanthes flaccidifolius Nees and Indig oferatinctoria Linn. International Journal of Plant Physiology and Biochemistry. 2011; 3(7):108-116.
- Rampogu S, Baek A, Gajula RG, et al. Ginger (Zingiber officinale) phytochemicals-gingerenone-A and shogaol inhibit SaHPPK: molecular docking, molecular dynamics simulations and in vitro approaches. Ann Clin Microbiol Antimicrob. 2018; 17(1):16. https://doi.org/10.1186/s12941-018-0266-9
- Aneja V, et al. Plant review. Phyto-pharmacology of Hemidesmus indicus. Pharmacognosy Reviews. 2008; 2(3):143-150.
- Bharathajothi P, Bhaaskaran CT. Phytochemical and pharmacological evaluations of Aristolochia bracteolata Lam. Asian Journal of Plant Science and Research. 2014; 4(6):15-19.
- Champagnat P. A Study on the composition of commercial Vetiveria zizanioides oils from different geographical origins. Journal of Essential Oil Research. 2011; 416-422. https://doi.org/10.1080/10412905.2006.9699129
- Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBPP. Licorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res. 2018; 32(12):2323-2339. https://doi.org/10.1002/ptr.6178
- Ashokkumar K, et al. Phytochemical variations among four distinct varieties of Indian cardamom Elettaria cardamomum (L.) Maton. Nat Prod Res. 2020; 34(13):1919-1922. https://doi.org/10.1080/14786419.2018.1561687
- Vadnere GP. Phytochemical Investigation and in-vitro antimicrobial screening of santalum album seeds extracts. International Journal of Pharmacy and Pharmaceutical Sciences. 2017; 9(10):117-24. https://doi.org/10.22159/ijpps.2017v9i11.21216
- Maurya DK. Evaluation of Yashtimadhu (Glycyrrhiza glabra) active phytochemicals against Novel Coronavirus (SARS-CoV-2). Austin J Pharmacol Ther. 2021; 9(6):1153. https://doi.org/10.26420/ austinjpharmacolther.2021.1153
- Foka FET, Manamela N, Mufamadi SM, Mufhandu HT. Potential of Azadirachta indica as a capping agent for antiviral nanoparticles against SARS-CoV-2. Biomed Res Int. 2022; 5714035. PMID: 36158879; PMCID: PMC9499809. https://doi.org/10.1155/2022/5714035
- Ahkam, Ahmad, Hermanto E, Feri, Alamsyah, Adzral, Aliyyah, Iva, Fatchiyah, Fatchiyah. Virtual prediction of antiviral potential of ginger (Zingiber officinale) bioactive compounds against spike and MPro of SARS-CoV2 protein. Berkala Penelitian Hayati. 2020; 25:52-57. https://doi.org/10.23869/bphjbr.25.2.20207